Indeed, alterations of lipid metabolism have been observed in AD brain, and several genes associated with late onset AD (LOAD) risk that control lipid metabolism (e.g., TREM2, APOE) are highly expressed in microglia [10, 24]. This evidence concerns the gene TREM2 and Alzheimer disease.